Insider Transactions in Q2 2021 at Kiora Pharmaceuticals Inc (KPRX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
155
-0.99%
|
$620
$4.19 P/Share
|
|
Jun 04
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
155
-0.98%
|
$620
$4.19 P/Share
|
|
Jun 04
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-0.76%
|
$720
$4.19 P/Share
|
|
Jun 04
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
878
-1.24%
|
$3,512
$4.19 P/Share
|
|
May 04
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
191
-1.2%
|
$764
$4.13 P/Share
|
|
May 04
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
158
-0.99%
|
$632
$4.13 P/Share
|
|
May 04
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
177
-0.74%
|
$708
$4.13 P/Share
|
|
May 04
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
889
-1.24%
|
$3,556
$4.13 P/Share
|
|
Apr 08
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-1.19%
|
$768
$4.94 P/Share
|
|
Apr 08
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-1.2%
|
$776
$4.94 P/Share
|
|
Apr 08
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-0.75%
|
$720
$4.94 P/Share
|
|
Apr 08
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
899
-1.23%
|
$3,596
$4.94 P/Share
|